Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer

por Kolijn, Kimberley, Verhoef, Esther I., van Leenders, Geert J.L.H.
Publicado 2015

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading

por van Leenders, Geert J L H, Verhoef, Esther I, Hollemans, Eva
Publicado 2020

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis

por Hollemans, Eva, Verhoef, Esther I., Bangma, Chris H., Rietbergen, John, Helleman, Jozien, Roobol, Monique J., van Leenders, Geert J.L.H.
Publicado 2018

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Rietbergen, John, Roobol, Monique J, Helleman, Jozien, van Leenders, Geert J L H
Publicado 2020

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Schoots, Ivo, Rietbergen, John, Helleman, Jozien, Roobol, Monique J, van Leenders, Geert J L H
Publicado 2019

Combined transmission, dark field and fluorescence microscopy for intact, 3D tissue analysis of biopsies

por Boamfa, Marius I., Asselman, Michel J. A., Vulders, Roland C. M., Verhoef, Esther I., van Royen, Martin E., van der Zaag, Pieter J.
Publicado 2020

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer

por Böttcher, René, Hoogland, A. Marije, Dits, Natasja, Verhoef, Esther I., Kweldam, Charlotte, Waranecki, Piotr, Bangma, Chris H., van Leenders, Geert J.L.H., Jenster, Guido
Publicado 2015

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases

por Böttcher, René, Dulla, Kalyan, van Strijp, Dianne, Dits, Natasja, Verhoef, Esther I., Baillie, George S., van Leenders, Geert J.L.H., Houslay, Miles D., Jenster, Guido, Hoffmann, Ralf
Publicado 2016

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

por Sieuwerts, Anieta M., Doebar, Shusma C., de Weerd, Vanja, Verhoef, Esther I., Beauford, Corine M., Agahozo, Marie C., Martens, John W.M., van Deurzen, Carolien H.M.
Publicado 2019

Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer

por Duijvesz, Diederick, Rodriguez‐Blanco, Giovanny, Hoogland, A. Marije, Verhoef, Esther I., Dekker, Lennard J., Roobol, Monique J., van Leenders, Geert J. L. H., Luider, Theo M., Jenster, Guido
Publicado 2019

Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns

por Verhoef, Esther I., van Cappellen, Wiggert A., Slotman, Johan A., Kremers, Gert-Jan, Ewing-Graham, Patricia C., Houtsmuller, Adriaan B., van Royen, Martin E., van Leenders, Geert J. L. H.
Publicado 2019

Three‐dimensional architecture of common benign and precancerous prostate epithelial lesions

por Verhoef, Esther I, van Cappellen, Wiggert A, Slotman, Johan A, Kremers, Gert‐Jan, Ewing‐Graham, Patricia C, Houtsmuller, Adriaan B, van Royen, Martin E, van Leenders, Geert J L H
Publicado 2019

MET expression during prostate cancer progression

por Verhoef, Esther I., Kolijn, Kimberley, De Herdt, Maria J., van der Steen, Berdine, Hoogland, A. Marije, Sleddens, Hein F.B.M., Looijenga, Leendert H.J., van Leenders, Geert J.L.H.
Publicado 2016

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients

por Hollemans, Eva, Verhoef, Esther I., Bangma, Chris H., Rietbergen, John, Osanto, Susanne, Pelger, Rob C. M., van Wezel, Tom, van der Poel, Henk, Bekers, Elise, Helleman, Jozien, Roobol, Monique J., van Leenders, Geert J. L. H.
Publicado 2020

Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients

por Hansum, Tim, Hollemans, Eva, Verhoef, Esther I., Bangma, Chris H., Rietbergen, John, Osanto, Susanne, Pelger, Rob C. M., van Wezel, Tom, van der Poel, Henk, Bekers, Elise, Helleman, Jozien, Remmers, Sebastiaan, van Leenders, Geert J. L. H.
Publicado 2021

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

por De Herdt, Maria J., Willems, Stefan M., van der Steen, Berdine, Noorlag, Rob, Verhoef, Esther I., van Leenders, Geert J.L.H., van Es, Robert J.J., Koljenović, Senada, de Jong, Robert J. Baatenburg, Looijenga, Leendert H.J.
Publicado 2016

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

por Rodríguez-Blanco, Giovanny, Zeneyedpour, Lona, Duijvesz, Diederick, Hoogland, A. Marije, Verhoef, Esther I., Kweldam, Charlotte F., Burgers, Peter C., Smitt, Peter Sillevis, Bangma, Chris H., Jenster, Guido, van Leenders, Geert J.L.H., Dekker, Lennard J.M., Luider, Theo M.
Publicado 2018

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling

por Van Hemelryk, Annelies, Tomljanovic, Ingrid, de Ridder, Corrina M. A., Stuurman, Debra C., Teubel, Wilma J., Erkens-Schulze, Sigrun, Verhoef, Esther I., Remmers, Sebastiaan, Mahes, Amrish J., van Leenders, Geert J. L. H., van Royen, Martin E., van de Werken, Harmen J. G., Grudniewska, Magda, Jenster, Guido W., van Weerden, Wytske M.
Publicado 2022